Skip to content

Canagliflozin Impurity 6

Canagliflozin Impurity 6

Product Description
CAT No.
ALN-C010019
CAS No.
2161394-96-1
Mol. F.
C48H50F2O11S2
Mol. Wt.
905
Stock
Please Inquire
Chemical Name : (2R,3R,4S,5R)-1-(2-Fluoro-5-(5-(2-methyl-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)benzyl)thiophen-2-yl)phenyl)-1-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)hexane-1,2,3,4,5,6-hexaol
Smiles : FC1=CC=C(C=C1C(C2=CC=C(C)C(CC3=CC=C(C4=CC=C(F)C=C4)S3)=C2)(O)[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO)C(S5)=CC=C5CC6=C(C)C=CC([C@@]7([H])[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)=C6
Inchi : InChI=1S/C24H25FO6S/c1-13-2-3-15(21(28)23(30)24(31)22(29)19(27)12-26)10-16(13)11-18-8-9-20(32-18)14-4-6-17(25)7-5-14/h2-10,19,22-24,26-27,29-31H,11-12H2,1H3/t19-,22-,23+,24+/m1/s1

Development and validation of HPLC method for determination of trace level potential genotoxic hydroperoxide impurity in canagliflozin

By Gosar, Amit; Shaikh, Tabrez; Botkondle, Suresh; Mahadik, Neelam; Tole, RahulnFrom International Journal of Pharma Research and Health Sciences (2019), 7(5), 3068-3071

Bioanalytical method development and validation of canagliflozin in human plasma by liquid chromatography-tandem mass spectrometry

By Deepan, T.; Rao, M. V. Basaveswara; Dhanaraju, M. D. – From Asian Journal of Pharmaceutical and Clinical Research (2019), 12(8), 46-51

Request For Quotation